Last updated on April 2019

A Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Urothelial Carcinoma - (FIGHT-201)


Brief description of study

The purpose of this study is to evaluate the overall response rate (ORR) of pemigatinib as a monotherapy in the treatment of metastatic or surgically unresectable urothelial carcinoma harboring FGF/FGFR alterations.

Clinical Study Identifier: NCT02872714

Find a site near you

Start Over

Sharp Memorial Hospital

San Diego, CA United States
  Connect »

Mount Sinai Medical Center

Miami Beach, FL United States
  Connect »

GU Research Network

Omaha, NE United States
  Connect »

Northwell Cancer Institute

New Hyde Park, NY United States
  Connect »

University of Rochester

Rochester, NY United States
  Connect »

Oncology Hematology Care, Inc.

Cincinnati, OH United States
  Connect »

St. Luke's Hospital

Bethlehem, PA United States
  Connect »

VA Pittsburgh Healthcare System

Pittsburgh, PA United States
  Connect »

Carolina Urologic Research Center

Myrtle Beach, SC United States
  Connect »

Texas Oncology

Houston, TX United States
  Connect »

Huntsman Cancer Institute

Salt Lake City, UT United States
  Connect »

Medical College of Wisconsin

Milwaukee, WI United States
  Connect »

UZ Antwerpen

Edegem, Belgium
  Connect »

AZ Delta

Roeselare, Belgium
  Connect »

Rigshospitalet

Copenhagen, Denmark
  Connect »

ICO - Site Paul Papin

Angers Cedex 9, France
  Connect »

Hopital Saint Louis

Paris Cedex 10, France
  Connect »

Centre Leon Berard

Lyon Cedex 8, France
  Connect »

VU Medisch Centrum

Amsterdam, Netherlands
  Connect »

Zorgsaam Ziekenhuis

Terneuzen, Netherlands
  Connect »

Guy's Hospital

London, United Kingdom
  Connect »

Charing Cross Hospital

London, United Kingdom
  Connect »

Queen Elizabeth Hospital

Birmingham, United Kingdom
  Connect »

Saitama Cancer Center

Kitaadachi-gun, Japan
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.